Literature DB >> 15582726

Augmentation of cocaine hyperactivity in rats by systemic ghrelin.

Paul J Wellman1, Kristina W Davis, Jack R Nation.   

Abstract

The feeding-relevant pathway by which food deprivation (FD) augments cocaine action is unknown. Systemic administration of the 28 amino acid acylated peptide ghrelin (1-10 nmol) increases food intake in rats and circulating levels of rat ghrelin are up-regulated by FD. The present experiment examined the impact of ghrelin or vehicle pretreatment on the locomotion and stereotypy induced by systemic cocaine hydrochloride. Male Sprague-Dawley rats were pretreated at -60 min with 0 or 5 nmol rat ghrelin (IP) and then injected (IP) at time 0 with 0, 2.5, 5.0, or 10.0 mg/kg cocaine. Locomotor activity was monitored over a 45-min post-cocaine period. Rats received the same ghrelin dose, but a different cocaine dose (in random order) on each of the four drug trials, with each drug trial separated by at least 2 days. Administration of 5 nmol ghrelin-0 mg/kg cocaine slightly increased locomotion relative to that of 0 nmol ghrelin-0 mg/kg cocaine. Cocaine increased locomotion as a function of dose in the 0 nmol ghrelin group, but the effect of cocaine was even greater when preceded by 5 nmol ghrelin. These results indicate that acute injection of ghrelin, at a feeding-relevant dose, augments the acute effects of cocaine on locomotion in rats.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15582726     DOI: 10.1016/j.regpep.2004.08.013

Source DB:  PubMed          Journal:  Regul Pept        ISSN: 0167-0115


  42 in total

Review 1.  Calculating utility: preclinical evidence for cost-benefit analysis by mesolimbic dopamine.

Authors:  Paul E M Phillips; Mark E Walton; Thomas C Jhou
Journal:  Psychopharmacology (Berl)       Date:  2006-11-22       Impact factor: 4.530

2.  Augmented cocaine conditioned place preference in rats pretreated with systemic ghrelin.

Authors:  Kristina W Davis; Paul J Wellman; P Shane Clifford
Journal:  Regul Pept       Date:  2007-01-24

3.  Impact of food restriction and cocaine on locomotion in ghrelin- and ghrelin-receptor knockout mice.

Authors:  Shane Clifford; Rosie Albarran Zeckler; Sam Buckman; Jeff Thompson; Nigel Hart; Paul J Wellman; Roy G Smith
Journal:  Addict Biol       Date:  2010-11-04       Impact factor: 4.280

4.  Ghrelin mediates stress-induced food-reward behavior in mice.

Authors:  Jen-Chieh Chuang; Mario Perello; Ichiro Sakata; Sherri Osborne-Lawrence; Joseph M Savitt; Michael Lutter; Jeffrey M Zigman
Journal:  J Clin Invest       Date:  2011-06-23       Impact factor: 14.808

Review 5.  The genetic epidemiology of substance use disorder: A review.

Authors:  Elizabeth C Prom-Wormley; Jane Ebejer; Danielle M Dick; M Scott Bowers
Journal:  Drug Alcohol Depend       Date:  2017-08-01       Impact factor: 4.492

Review 6.  Role of ghrelin in the pathophysiology of eating disorders: implications for pharmacotherapy.

Authors:  Sebastian Cardona Cano; Myrte Merkestein; Karolina P Skibicka; Suzanne L Dickson; Roger A H Adan
Journal:  CNS Drugs       Date:  2012-04-01       Impact factor: 5.749

7.  Ghrelin receptor antagonism attenuates cocaine- and amphetamine-induced locomotor stimulation, accumbal dopamine release, and conditioned place preference.

Authors:  Elisabet Jerlhag; Emil Egecioglu; Suzanne L Dickson; Jörgen A Engel
Journal:  Psychopharmacology (Berl)       Date:  2010-06-19       Impact factor: 4.530

8.  Systemic ghrelin sensitizes cocaine-induced hyperlocomotion in rats.

Authors:  Paul J Wellman; Chelsie N Hollas; Audrea E Elliott
Journal:  Regul Pept       Date:  2007-07-29

9.  Effect of food restriction on cocaine locomotor sensitization in Sprague-Dawley rats: role of kappa opioid receptors.

Authors:  Craig P Allen; Yan Zhou; Francesco Leri
Journal:  Psychopharmacology (Berl)       Date:  2012-12-02       Impact factor: 4.530

10.  Assessing the role of the growth hormone secretagogue receptor in motivational learning and food intake.

Authors:  Alexander W Johnson; Rebecca Canter; Michela Gallagher; Peter C Holland
Journal:  Behav Neurosci       Date:  2009-10       Impact factor: 1.912

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.